Cargando…
Pre-Clinical Drug Prioritization via Prognosis-Guided Genetic Interaction Networks
The high rates of failure in oncology drug clinical trials highlight the problems of using pre-clinical data to predict the clinical effects of drugs. Patient population heterogeneity and unpredictable physiology complicate pre-clinical cancer modeling efforts. We hypothesize that gene networks asso...
Autores principales: | Xiong, Jianghui, Liu, Juan, Rayner, Simon, Tian, Ze, Li, Yinghui, Chen, Shanguang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978107/ https://www.ncbi.nlm.nih.gov/pubmed/21085674 http://dx.doi.org/10.1371/journal.pone.0013937 |
Ejemplares similares
-
Protein-protein Interaction Reveals Synergistic Discrimination of Cancer Phenotype
por: Xiong, Jianghui, et al.
Publicado: (2010) -
Genome wide prediction of protein function via a generic knowledge discovery approach based on evidence integration
por: Xiong, Jianghui, et al.
Publicado: (2006) -
Predicting Response to Preoperative Chemotherapy Agents by Identifying Drug Action on Modeled MicroRNA Regulation Networks
por: Zhu, Lida, et al.
Publicado: (2014) -
Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers
por: Xu, Li, et al.
Publicado: (2015) -
Correction: Comparison of the Prognostic Utility of Diverse Molecular Data among lncRNA, DNA Methylation, microRNA and mRNA across Five Human Cancers
por: Xu, Li, et al.
Publicado: (2016)